Barclays lowered the firm’s price target on Thermo Fisher to $610 from $625 and keeps an Overweight rating on the shares post the Q1 results. The analyst says the company’s "differentiated" integrated model and balanced portfolio gives it insulation from industry-specific issues and sets the company up for consistent sales and earnings growth.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TMO:
- Thermo Fisher Scientific Earnings Update: Did it Beat Estimate Forecasts?
- Thermo Fisher backs FY23 adjusted EPS view $23.70, consensus $23.71
- Thermo Fisher Slides on Weak Q1
- Thermo Fisher reports Q1 adjusted EPS $5.03, consensus $5.03
- Thermo Fisher, Devyser Diagnostics enter NGS products distribution agreement